NLVP

New Leaf Venture Partners Portfolio holdings

AUM $52.9M
This Quarter Return
-26.85%
1 Year Return
-33.65%
3 Year Return
+15.24%
5 Year Return
+39.89%
10 Year Return
+615.06%
AUM
$110M
AUM Growth
+$110M
Cap. Flow
+$667K
Cap. Flow %
0.6%
Top 10 Hldgs %
96.16%
Holding
13
New
3
Increased
2
Reduced
2
Closed
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
PDSB icon
1
PDS Biotechnology
PDSB
$57.8M
$21.5M 19.42% 2,344,868
ARAV
2
DELISTED
Aravive, Inc. Common Stock
ARAV
$16.4M 14.8% 2,039,223
DMTX
3
DELISTED
Dimension Therapeutics, Inc
DMTX
$16.1M 14.59% 2,059,283
OXFD
4
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$13.7M 12.35% 1,377,497
WVE icon
5
Wave Life Sciences
WVE
$1.53B
$10.9M 9.85% 784,159
DVAX icon
6
Dynavax Technologies
DVAX
$1.19B
$9.54M 8.64% 496,042 -50,956 -9% -$980K
ALDR
7
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
$6.07M 5.49% 247,806 -252,592 -50% -$6.19M
SAGE
8
DELISTED
Sage Therapeutics
SAGE
$4.57M 4.14% +142,570 New +$4.57M
DERM
9
DELISTED
Dermira, Inc.
DERM
$3.8M 3.44% 183,884 +6,862 +4% +$142K
MRNS
10
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$3.79M 3.43% 704,572
CMRX
11
DELISTED
Chimerix, Inc.
CMRX
$2.98M 2.7% 582,904 +362,371 +164% +$1.85M
INCY icon
12
Incyte
INCY
$16.5B
$1.16M 1.05% +16,000 New +$1.16M
KPTI icon
13
Karyopharm Therapeutics
KPTI
$61.7M
$109K 0.1% +12,226 New +$109K